Joimax saw 30% increase in 2017 consolidated sales: 5 highlights

Written by Megan Wood | February 09, 2018 | Print  |

Joimax recorded a nearly 30 percent increase in consolidated sales in 2017 compared to 2016.

Here are five highlights:

 

1. The company's sales have grown at a 35 percent compound annual growth rate since 2008.

 

2. Joimax has a footprint in 50 countries, focusing on Europe, Asia and the U.S.

 

3. The company credits the American Medical Association CPT code 62380 for endoscopic decompression of the lumbar spine, effective in January 2017, as driving its success in the U.S.

 

4. Joimax recently received approval for its Endovapor 2 Multi Radio Frequency System in Asia, allowing the company to market its portfolio of systems in China.

 

5. With the increasing focus on SI joint treatment, joimax is hopeful for its success with its MultiZYTE Facet and SI Joint Treatment Set offering.

 

More articles on MIS:
4 spine surgeons weigh the pros & cons of robotic image guidance
HSS researchers develop brachial plexus surgery, surgical outcomes impact assessment: 4 key insights
Fusion vs. decompression alone for degenerative spondylolisthesis patients: 5 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months